Related Experiment Videos
Effects of hormone replacement therapy on ocular function in postmenopause.
Pietro Affinito1, Attilio Di Spiezio Sardo, Constantino Di Carlo
1Department of Gynecology and Obstetrics, and Pathophysiology of Human Reproduction, University of Naples, Naples, Italy.
Summary
Hormone replacement therapy significantly improved ocular symptoms and increased tear production in postmenopausal women. It also reduced intraocular pressure and slightly increased corneal thickness.
Area of Science:
- Ophthalmology
- Endocrinology
- Women's Health
Background:
- Menopause is associated with various physiological changes, including ocular complaints.
- Hormonal fluctuations during menopause can impact eye health, leading to dry eye and other symptoms.
Purpose of the Study:
- To investigate the effects of hormone replacement therapy (HRT) on climacteric ocular complaints.
- To assess HRT's impact on lacrimal secretion, intraocular pressure (IOP), and corneal thickness in postmenopausal women.
Main Methods:
- A randomized controlled study involving 50 healthy postmenopausal women.
- Group A received transdermal 17beta-estradiol and medroxyprogesterone acetate; Group B served as the control.
- Ocular examinations, lacrimal secretion, IOP, and corneal thickness were measured at baseline, 3, and 6 months.
Main Results:
- HRT significantly reduced the prevalence and severity of ocular symptoms compared to baseline and controls.
- A significant increase in both basal and stimulated lacrimal secretion was observed after 3 months of HRT.
- Intraocular pressure (IOP) significantly decreased after 3 months of HRT, with a slight, non-significant increase in corneal thickness.
Conclusions:
- Hormone replacement therapy demonstrates a beneficial effect on ocular health in postmenopausal women.
- HRT can alleviate dry eye symptoms, enhance tear production, and lower intraocular pressure.
- The findings suggest HRT as a potential therapeutic option for managing menopausal ocular complaints.